Michael Dougherty > DLA Piper LLP (US) > New York, United States > Lawyer Profile

DLA Piper LLP (US)
1251 AVENUE OF THE AMERICAS
NEW YORK, NY 10020-1104
United States

Work Department

Intellectual Property and Technology; Patent Litigation; Life Sciences

Position

Partner

Career

In his 30-year career as a patent litigator, Michael Dougherty has made protecting his pharmaceutical and biotechnology clients’ products his primary goal.

Representing brand pharmaceuticals in suits against generic drug companies under the Hatch-Waxman Act is a cornerstone of his practice. Mike represents some of the top drug makers in the world, and his record of success includes wins for many of them. He regularly appears before US district courts and the Court of Appeals for the Federal Circuit, as well as the International Trade Commission.

With his keen insight into the industry and his own background in biology, Mike understands the science behind his clients’ products and guides them through the complex patent issues involved in the development of new ones. He has vast experience with Abbreviated New Drug Applications (ANDAs), conducts due diligence investigations concerning intellectual property portfolios, and handles Section 337 investigations in the US International Trade Commission.

Education

J.D., College of William and Mary School of Law; B.A., Case Western Reserve University

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

DLA Piper LLP (US) demonstrates particular strength in complex cross-border disputes involving the US as a key international patent venue. With expertise in district courts, the Federal Circuit, the ITC and the PTAB, the practice offers the full range of litigation skills thanks to its deep bench of first chair trial lawyers and often acts in matters involving several domestic venues. Many international and US giants from a diverse sector range rely on the practice’s expertise, including technology, electronics, consumer products, semiconductor and automotive clients. Increasingly, the group also acts for clients from the media and entertainment sector. In 2019, the firm grew its Hatch-Waxman practice with the arrival of Michael Sitzman, formerly of Gibson, Dunn & Crutcher LLP, and Soumitra Deka, formerly of Arnold & Porter, in the San Francisco office. In New York, Tony Pezzano and of counsel Michael Dougherty from Hogan Lovells US LLP also bolstered the life sciences bench. Further strategic changes were the arrival of patent and trade secret litigator Michael Jay from Boies Schiller Flexner LLP in Los Angeles and the strengthening of the firm’s technical expertise in artificial intelligence, machine learning and blockchain matters with the recruitment of former McDonnell Boehnen Hulbert & Berghoff LLP practitioner Lisa Hillman to the Boston office. The arrival of former Nixon Peabody LLP patent experts Maria Swiatek and Christopher Mooney in the Silicon Valley office and the recruitment of former Venable LLP life sciences specialist Michael Furrow were another key events. Other important offices are in New York, San Diego, Chicago, Austin, Reston and Wilmington. Sean Cunningham in San Diego US patent litigation practice, with Matthew Satchwell in Chicago and Kathryn Grasso, who splits her time between the San Diego and Washington DC offices, are acting as vice chairs. Mark Fowler in Silicon Valley is the vice chair of the intellectual property and technology practice. Eric Hagen left for an in-house position at Austin FC. Gerald Sekimura retired.